Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after β-blocker or angiotensin-converting enzyme inhibitor therapy

Journal of Nuclear Medicine

Volumn 40, Issue 2, 1999, Pages 217-223

  Toyama, Takuji ^a,b   Aihara, Yasushi ^a   Iwasaki, Tsutomu ^a   Hasegawa, Akira ^a   Suzuki, Tadashi ^a   Nagai, Ryozo ^a   Endo, Keigo ^a   Hoshizaki, Hiroshi ^a   Oshima, Shigeru ^a   Taniguchi, Koichi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Gunma Cancer Center   (Japan)

Author keywords

blocker; 123I metaiodobenzylguanidine; Angiotensin converting enzyme inhibitor; Dilated cardiomyopathy

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ENALAPRIL; IODINE 123; METOPROLOL;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DRUG EFFECT; FEMALE; FOLLOW UP; HEART DILATATION; HEART INNERVATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SCINTISCANNING; HUMAN; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC TONE;

3-IODOBENZYLGUANIDINE; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; MALE; METOPROLOL; MIDDLE AGED; RADIOPHARMACEUTICALS; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032983679     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN. The neurohumoral axis in congestive heart failure. Ann Intern Med. 1984;101:370-377.
2. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
3. Baim DS, McDowell AV, Cherniles J, et al. Evaluation of a new bipyridine inotropic agent-milrinone in patients with severe congestive heart failure. N Engl J Med. 1983;309:748-756.
4. Maskin CS, Sinoway L, Chadwick B, Sonnenblick EH, Le Jemtel TH. Sustained hemodynamic and clinical effects of a new cardiotonic agent, Win 47203, in patients with severe congestive heart failure. Circulation. 1983;67:1065-1070.
5. Petein M, Levine TB, Cohn JN. Persistent hemodynamic effects without long-term clinical benefits in response to oral proximone (MDL 19.205) in patients with congestive heart failure. Circulation. 1986;73:230-236.
6. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R, for the Milrinone Multicenler Trial Group. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989;320:677-683.
7. Cohn JN. Inotropic therapy for heart failure: paradise postponed. N Engl J Med. 1989;320:729-731.
8. Engelmeier RS, O'Connell JB, Walsh R, Rad N, Scanlon PJ, Gunmar R. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation. 1985;72:536-546.
9. Anderson JL, Lutz JR, Gilbert EM, et al. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol. 1985;55:471-475.
10. Schofer J, Spielmann R, Schbert A, Weber K, Schluter M. Iodine-123 metaiodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1988;12:1252-1258.
11. Merlet P, Valette H, Dubois-Randé JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
12. Sahn DJ, DeMaria A, Kissio J, Weyman A. Recommendations regarding quantitation in M-Mode echocardiography: result of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
13. Teicholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1976;37:7.
14. Kline RC, Swanson DP, Wieland DM, et al. Myocardial imaging in man with I-123 meta-iodobenzyl guanidine. J Nucl Med. 1981;22:29-132.
15. Wieland DM, Brown LE, Rogers WL. et al. Myocardial imaging with a radioiodinate norepinephrine storage analog. J Nucl Med. 1981;22:22-31.
16. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jaques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med. 1987;28:1620-1624.
17. Tobes MC, Jaques S JR, Wieland DM, Sisson JC. Effect of uptake one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med. 1985;26:897-907.
18. Gasnier B, Roisin MP, Scherman D, Coornaert S, Desplanches G, Henry JP. Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes. Mol Pharmacol. 1986;29:275-280.
19. Nakajo M, Shimabukuro Y, Yoshimura H, et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med. 1986;27:84-89.
20. Glowniak JV, Turner FE, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123-metaiodobenzylguanidine imaging of the heart on idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med. 1989;30:1182-1191.
21. Dae MW, Marco TD, Botvinick EH, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts-Implications for clinical studies. J Nucl Med. 1992;33:1444-1450.
22. Nishimura T, Morozumi T, Hori M. I-123 MIBG scintigraphy for the estimation of the beta-blocker therapy in patients with dilated cardiomyopathy: a multicenter trial [abstract]. J Nucl Med. 1996;37:183P.
23. Alderman J, Grossman W. Are beta-adrenargic-blocking drugs useful in the treatment of dilated cardiomyopathy? Circulation. 1985;71:854-857.
24. Woodley SL, Gilbert EM, Anderson JL, et al. Beta-blockade with bucindololin heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991;84:2426-2441.
25. Yamada T, Fukunami M, Ohmori M, et al. Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? J Am Coll Cardiol. 1993;21:628-633.
26. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
27. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-310.
28. Waagstein F, Caidahl K, Wallentin I, Bergh CH, Hjalmarson A. Long-term beta-blockade in dilated cardiomyopathy. Circulation. 1989;80:551-563.
29. Erlebacher JA, Bhardwaj M, Suresh A, Leber GB, Goldweit RS. Beta-blocker treatment of idiopathic and ischemic dilated cardiomyopathy in patients with ejection fraction ≤20%. Am J Cardiol. 1993;71:1457-1469.
30. Wagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 1993;342:1441-1446.
31. Bristow MR, O'Connel JB, Gilbert EM, et al. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Circulation. 1994;89:1632-1642.
32. CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure. The cardiac insufficiency bisoprolol study (CIBIS). Circulation. 1994;90: 1765-1773.
33. Gilbert EM, Abraham WT, Olsen S, et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation. 1996;94:2817-2825.
34. Ader R, Chatterjee K, Ports T, Brundage B, Hiramatsu B, Parmley W. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin converting enzyme inhibitor. Circulation. 1980;61:931-937.
35. Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory congestive heart failure. J Am Coll Cardiol. 1988;62:41A-45A.
36. Spinale FG, Holzgrefe HH, Mukherjee R, et al. Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy. Effects on left ventricular and myocyte structure and function. Circulation. 1995;92:562-578.